Sanjay S. Subramanian
2023
In 2023, Sanjay S. Subramanian earned a total compensation of $1M as Senior Vice President and Chief Financial Officer at Inozyme Pharma, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,000 |
|---|---|
| Option Awards | $406,704 |
| Salary | $444,333 |
| Other | $9,900 |
| Total | $1,032,937 |
Subramanian received $444.3K in salary, accounting for 43% of the total pay in 2023.
Subramanian also received $172K in non-equity incentive plan, $406.7K in option awards and $9.9K in other compensation.
Rankings
In 2023, Sanjay S. Subramanian's compensation ranked 1,168th out of 2,983 executives tracked by ExecPay. In other words, Subramanian earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,168 out of 2,983 | 61st |
Division Manufacturing | 696 out of 1,637 | 58th |
Major group Chemicals And Allied Products | 464 out of 906 | 49th |
Industry group Drugs | 453 out of 869 | 48th |
Industry Pharmaceutical Preparations | 311 out of 627 | 50th |
Source: SEC filing on April 26, 2024.
Subramanian's colleagues
We found three more compensation records of executives who worked with Sanjay S. Subramanian at Inozyme Pharma in 2023.